TELIX PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.8 AUD | -4.21% |
|
-3.58% | +46.83% |
| 05-03 | Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP | MT |
| 04-30 | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Other Biotechnology & Medical Research | -4.21% | -3.58% | +46.83% | +30.28% | +1,601.15% | 3.41B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- TLX Stock
- Charts Telix Pharmaceuticals Limited
- Comparison Chart
